Trademark: REVLIMID
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REVLIMID
We do not have any records of a proof of use for REVLIMID at this moment.
Possible trademark infringements of REVLIMID
Basic Information about REVLIMID
- Serial Number
- 76631301
- Filing Date
- 14 Feb 2005
- Registration Number
- 3169244
- Registration Date
- 07 Nov 2006
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of REVLIMID on the blockchain with WikiTrademarks.io.
- First use of REVLIMID anywhere
- REVLIMID was first used on 30 Nov 2005 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns REVLIMID?
Correspondent
- Marilyn F. Kelly
- Bristol-Myers Squibb Company
- Trademark Dept., Mailstop D.4243
- PO BOX 4000
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io